These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2612863)

  • 1. [Neuroleukemia in mice with leukemia L1210 treated with methotrexate].
    Petrov SA
    Gematol Transfuziol; 1989 Nov; 34(11):46-50. PubMed ID: 2612863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphogenesis of experimental neuroleukemia].
    Petrov SA
    Arkh Patol; 1994; 56(2):25-7. PubMed ID: 8037587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transplantability, development and methotrexate sensitivity of mouse leukemia L1210 resistant to olivomycin].
    Prokhorova EV
    Antibiotiki; 1978 Jun; 23(6):553-7. PubMed ID: 677843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
    Shorin VA; Bazhanov VS
    Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic changes associated with resistance to methotrexate and 6-mercaptopurine in L1210 ascites lymphoma.
    Calman NS; Eng B; Slater LM; Wallerstein H
    J Natl Cancer Inst; 1974 Mar; 52(3):997-8. PubMed ID: 4826575
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of tests of chemotherapeutic agents involving repeated drug treatment.
    Ullman NS; Jacquez JA
    Biometrics; 1973 Dec; 29(4):677-93. PubMed ID: 4785233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Initial morphological manifestations in experimental neuroleukemia].
    Petrov SA
    Eksp Onkol; 1990; 12(1):31-4. PubMed ID: 2298140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave treatment of intracerebral L1210 leukemia: schedule-dependent partial reversal of the effects of methotrexate.
    Chang BK; Huang AT; Joines WT
    Bioelectromagnetics; 1981; 2(1):77-80. PubMed ID: 7284044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of reserpine (NSC-59272)-induced hypothermia on lifespan in mouse L1210 leukemia.
    Fondy TP; Karker KL; Calcagnino C; Emlich CA
    Cancer Chemother Rep; 1974; 58(3):317-24. PubMed ID: 4841715
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of combination treatment with adriamycin and methotrexate on the survival time of leukemic (L 1210) mice.
    Miyakawa A; Padarathsingh M; Vadlamudi S; Goldin A
    Chemotherapy; 1973; 19(1):38-46. PubMed ID: 4747574
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL; Roberts D
    Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of methotrexate on the leukemic cell cycle in mouse ascitic leukemia L1210].
    Goncharova SA; Frankfurt OS
    Tsitologiia; 1975 Sep; 17(9):1051-6. PubMed ID: 1166521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ricin and abrin on survival of L1210 leukemic mice and on leukemic and normal bone-marrow cells.
    Fodstad O; Pihl A
    Int J Cancer; 1978 Nov; 22(5):558-63. PubMed ID: 721316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between 5,10-dideaza-5,6,7,8-tetrahydrofolic acid and methotrexate in mice bearing L1210 tumors.
    Ferguson K; Boschelli D; Hoffman P; Oronsky A; Whiteley J; Webber S; Galivan J; Freishiem J; Hynes J; Kerwar SS
    Cancer Chemother Pharmacol; 1989; 25(3):173-6. PubMed ID: 2598407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal methotrexate in the treatment of murine L1210 leukemia.
    Woo SY; Dilliplane P; Rahman A; Sinks LF
    Cancer Drug Deliv; 1983; 1(1):59-62. PubMed ID: 6544118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents.
    Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
    Sirotnak FM; Poser RE; Barrueco JR
    Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.